Ebglyss 250 mg (Lebrikizumab SOLUTION) 250 MG

EBGLYSS 250 MG is a subcutaneous solution containing lebrikizumab, used for managing moderate to severe atopic dermatitis. This medication helps reduce inflammation and improve skin condition.

Strength

250 MG

Manufacturer / TM Owner

ELI LILLY CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EBGLYSS 250 MG is primarily used for the treatment of moderate to severe atopic dermatitis in adults and children. It works by targeting specific proteins involved in the inflammatory process, helping to alleviate symptoms such as itching, redness, and skin lesions. People often ask, 'What is EBGLYSS used for?' and the answer lies in its ability to manage chronic skin conditions effectively.

Side Effects

Common effects of EBGLYSS 250 MG may include reactions at the injection site, such as redness, itching, or swelling. Some users might experience headaches, fatigue, or upper respiratory infections. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Precautions & Warnings

EBGLYSS 250 MG should be handled with care, ensuring proper storage and administration as directed. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

EBGLYSS 250 MG may interact with other medications, including those that suppress the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works, so it's important to discuss these factors with a healthcare professional.

Frequently Asked Questions

EBGLYSS 250 MG is used for the treatment of moderate to severe atopic dermatitis, helping to reduce inflammation and improve skin condition.

EBGLYSS 250 MG is administered subcutaneously, typically by a healthcare professional or as directed.

Common side effects may include injection site reactions, headaches, fatigue, and upper respiratory infections.

EBGLYSS 250 MG can be used by children for the treatment of atopic dermatitis, but it should be administered under the guidance of a healthcare provider.

EBGLYSS 250 MG should be stored as directed, typically in a refrigerator, to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.